This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Recently, a newly detected serum autoantibody (called NMO-IgG) has been reported to distinguish between neuromyelitis optica (NMO) and multiple sclerosis (MS),1 and revised diagnostic criteria for NMO giving a crucial role to this antibody have been suggested.2 This proposal has important clinical implications and therefore demands independent confirmation.
Patients.
We studied 36 unselected patients with NMO (33 relapsing, three monophasic). All patients met the 1999 criteria of Wingerchuk et al.3 Spinal cord lesions in three or more segments were present in 35 of 36. Median follow-up from onset was 38 months. In addition, we tested 80 patients with MS according to the revised McDonald criteria4 (71% relapsing-remitting, 20% secondary progressive, 9% primary progressive), five patients with longitudinally extensive transverse myelitis (LETM),1,5 11 patients with non-LETM myelitis, 21 with miscellaneous neurologic disorders, and 25 healthy controls.
Methods.
NMO-IgG was detected by indirect immunofluorescence.1 Briefly, adult mouse cerebellum cryosections (10 μm) were incubated with 10% phosphate-buffered formalin for 4 minutes. After three washes in phosphate-buffered saline (PBS), detergent (1% CHAPS in PBS) was applied for 4 minutes. After …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.